William Benton Jones - SVP, Pharmaceutical Development at Corvus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Pharmaceutical Development
Issuer Symbol
CRVS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by William Benton Jones since 05 Jan 2025

Holdings reported by William Benton Jones for Corvus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 173,130 $605,955 $3.50 04 Jun 2025 Direct
Stock Option (Right to Buy) 400,000 04 Dec 2025 Direct Common Stock
Warrant (Right to Buy) 0 04 Jun 2025 Direct Common Stock

Transactions reported by William Benton Jones for Corvus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.